Related references
Note: Only part of the references are listed.Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue
Claudio Vitali et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Role of Fms-like Tyrosine Kinase 3 Ligand as a Potential Biologic Marker of Lymphoma in Primary Sjogren's Syndrome
Gabriel J. Tobon et al.
ARTHRITIS AND RHEUMATISM (2013)
Tears as a source of biomarkers for ocular and systemic diseases
Nadine von Thun Und Hohenstein-Blaul et al.
EXPERIMENTAL EYE RESEARCH (2013)
CXCL13 is elevated in Sjogren's syndrome in mice and humans and is implicated in disease pathogenesis
Jill M. Kramer et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Autoimmune Rheumatic Diseases 1 Clinical aspects of autoimmune rheumatic diseases
Fiona Goldblatt et al.
LANCET (2013)
BIOMARKERS New biomarker for Sjogren's syndrome-time to treat patients
Frans G. M. Kroese et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sjogren's Syndrome. Data at Enrollment in the Prospective ASSESS Cohort
Jacques-Eric Gottenberg et al.
PLOS ONE (2013)
Sjogren's syndrome, the old and the new
Yogev Peri et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2012)
Novel autoantibodies in Sjogren's syndrome
Long Shen et al.
CLINICAL IMMUNOLOGY (2012)
Clinical significance and diagnostic usefulness of anti-centromere antibody in Sjogren's syndrome
Tetsutaro Kitagawa et al.
CLINICAL RHEUMATOLOGY (2012)
How to assess treatment efficacy in Sjogren's syndrome?
Arjan Vissink et al.
CURRENT OPINION IN RHEUMATOLOGY (2012)
Classification criteria for Sjogren's syndrome: A critical review
Chiara Baldini et al.
JOURNAL OF AUTOIMMUNITY (2012)
Autoantibodies in Sjögren's syndrome: Clinical presentation and regulatory mechanisms
Athanasios G. Tzioufas et al.
PRESSE MEDICALE (2012)
Tear analysis in ocular surface diseases
Lei Zhou et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2012)
Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity
Mark Baugh et al.
JOURNAL OF AUTOIMMUNITY (2011)
Identification of autoantibody biomarkers for primary Sjogren's syndrome using protein microarrays
Shen Hu et al.
PROTEOMICS (2011)
Preclinical Validation of Salivary Biomarkers for Primary Sjogren's Syndrome
Shen Hu et al.
ARTHRITIS CARE & RESEARCH (2010)
Increased Expression of Cathepsins and Obesity-Induced Proinflammatory Cytokines in Lacrimal Glands of Male NOD Mouse
Xiaodong Li et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
SALIVA AS A DIAGNOSTIC MEDIUM
Richard Pink et al.
BIOMEDICAL PAPERS-OLOMOUC (2009)
Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjogren's syndrome (SJS)-like disease of the C57BL/6.NOD-Aec1Aec2 mouse
Cuong Q. Nguyen et al.
EXPERIMENTAL EYE RESEARCH (2009)
Rapid serological detection of autoantibodies associated with Sjogren's syndrome
Peter D. Burbelo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Unraveling the Pathophysiology of Sjogren Syndrome-Associated Dry Eye Disease
Cuong Q. Nguyen et al.
OCULAR SURFACE (2009)
Cysteine cathepsins: Cellular roadmap to different functions
Klaudia Brix et al.
BIOCHIMIE (2008)
Salivary proteomic and genomic biomarkers for primary Sjogren's syndrome
Shen Hu et al.
ARTHRITIS AND RHEUMATISM (2007)
Pulmonary arterial hypertension: A rare complication of primary Sjogren syndrome - Report of 9 new cases and review of the literature
David Launay et al.
MEDICINE (2007)
Cutaneous findings in patients with primary Sjogren's syndrome
Mehmet Soy et al.
CLINICAL RHEUMATOLOGY (2007)
Clinical significance of autoantibodies recognizing Sjogren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjogren's syndrome
V. Goeb et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Interstitial lung disease in primary Sjogren syndrome
Joseph G. Parambil et al.
CHEST (2006)
Sjogren's syndrome: Why autoimmune epithelitis?
D. I. Mitsias et al.
ORAL DISEASES (2006)
Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development
SR da Costa et al.
EXPERIMENTAL EYE RESEARCH (2006)
Diagnostic potential of tear proteomic patterns in Sjdgren's syndrome
N Tomosugi et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo
C Beers et al.
JOURNAL OF IMMUNOLOGY (2005)
Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
C Vitali et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)